Advancing the World of Health

The name “embecta” represents the company’s commitment to people living with diabetes and its corporate heritage, with the “em-” prefix evoking empathy for people living with diabetes and the empowerment of the new company and the “bect” imbibed from Becton. Becton, Dickinson and Company (BD; also Becton Dickinson or Becton) is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD can help you identify potential “at-risk” patients, empower clinical intervention, and advance health system insights A unique ecosystem to collaborate on flow cytometry panel design, improve cytometer efficiency and manage your laboratory.

• Houses many of our pre-designed multicolor flow cytometry panels.
• Backed by cutting-edge technology and more than 50 years of flow cytometry expertise
• Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare.
• Explore our webinar series spanning a broad range of topics and in-depth reviews by senior scientists, professionals and clinicians.
• In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock.

BD Horizon RealBlue™ 705 Reagents

It allowed us to study gene expression from immune populations of frozen PBMCs from people living with HIV after a nutritional intervention. Fill out the form to receive updates on our latest products and innovations, exclusive promotions, educational tours, and other exciting news. Backed by cutting-edge technology and more than 50 years of flow cytometry expertise Designed and validated for use with cell suspensions, whole blood and tissue pieces. BD Horizon RealViolet™ 544 Reagents offer limited spillover, robust intracellular performance and lot-to-lot consistency. In December 2025, BD was sued by Tela Bio Inc., makers of a ovine forestomach matrix hernia mesh, who alleged that BD engaged in anticompetitive practices to push Tela out of the market for surgical meshes while raising prices for providers and patients.

Innovative solutions to power your diagnostics and research

BD can help you optimize clinical effectiveness to help drive improvement in patient outcomes Quality standards, cost controls and efficiency

Embecta Corporation is a standalone public company focused on diabetes care. Our Purpose drives us to create innovative solutions that make a meaningful impact on advancing the world of health™. Surgical efficiency, patient safety and outcomes, procedural cost management Use a variety of training courses for instruments and applications to take full advantage of the capabilities of BD products. Explore our webinar series spanning a broad range of topics and in-depth reviews eaub.info/ by senior scientists, professionals and clinicians.

Houses many of our pre-designed multicolor flow cytometry panels. Explore a variety of tools for your multicolor flow cytometry, from panel design to selection tools—an array of aids to support your research. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsody™ single-cell platform.